Evidence map›Paper›PMID 38578616›Full record

ArticleJournal of the American Medical Informatics Association : JAMIA2024

Can large language models provide secondary reliable opinion on treatment options for dermatological diseases?

Usman Iqbal, Leon Tsung-Ju Lee, Annisa Ristya Rahmanti, Leo Anthony Celi, Yu-Chuan Jack Li

Open access · greenAbstract read
In one paragraph

Article in Journal of the American Medical Informatics Association : JAMIA, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. [Large language models-hype or hope?]Dermatologie (Heidelberg, Germany) · 2025
    Article
  5. Article
  6. The Role of ChatGPT in Dermatology Diagnostics.Diagnostics (Basel, Switzerland) · 2025
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 4 countries.

Usman IqbalSchool of Population Health, Faculty of Medicine and Health, University of New South Wales (UNSW), Sydney, NSW 2052, Australia.ORCID 0000-0002-0614-123X
Leon Tsung-Ju LeeGraduate Institute of Clinical Medicine, Taipei Medical University, Taipei 110, Taiwan.
Annisa Ristya RahmantiGraduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan.
Leo Anthony CeliLaboratory for Computational Physiology, Massachusetts Institute of Technology, Cambridge, MA 02139, United States.
Yu-Chuan Jack LiGraduate Institute of Biomedical Informatics, College of Medical Science and Technology, Taipei Medical University, Taipei 110, Taiwan.
Beth Israel Deaconess Medical Center · USTaipei Medical University · TWTaipei Medical University Hospital · TWUniversitas Gadjah Mada · IDUniversity of Tasmania · AU

Funding

Higher Education Sprout Project MOE DP2-TMU-112-A-04Ministry of EducationNational Science and Technology Council 112-2321-B-038-006National Science and Technology Council NSTC 112-2321-B-038-006
6 · The paper itself

Abstract

objectiveTo investigate the consistency and reliability of medication recommendations provided by ChatGPT for common dermatological conditions, highlighting the potential for ChatGPT to offer second opinions in patient treatment while also delineating possible limitations. MATERIALS AND

methodsIn this mixed-methods study, we used survey questions in April 2023 for drug recommendations generated by ChatGPT with data from secondary databases, that is, Taiwan's National Health Insurance Research Database and an US medical center database, and validated by dermatologists. The methodology included preprocessing queries, executing them multiple times, and evaluating ChatGPT responses against the databases and dermatologists. The ChatGPT-generated responses were analyzed statistically in a disease-drug matrix, considering disease-medication associations (Q-value) and expert evaluation.

resultsChatGPT achieved a high 98.87% dermatologist approval rate for common dermatological medication recommendations. We evaluated its drug suggestions using the Q-value, showing that human expert validation agreement surpassed Q-value cutoff-based agreement. Varying cutoff values for disease-medication associations, a cutoff of 3 achieved 95.14% accurate prescriptions, 5 yielded 85.42%, and 10 resulted in 72.92%. While ChatGPT offered accurate drug advice, it occasionally included incorrect ATC codes, leading to issues like incorrect drug use and type, nonexistent codes, repeated errors, and incomplete medication codes.

conclusionChatGPT provides medication recommendations as a second opinion in dermatology treatment, but its reliability and comprehensiveness need refinement for greater accuracy. In the future, integrating a medical domain-specific knowledge base for training and ongoing optimization will enhance the precision of ChatGPT's results.

Indexed as

Skin DiseasesDatabases, FactualDermatologic AgentsHumansNatural Language ProcessingReferral and ConsultationReproducibility of ResultsTaiwanDermatologic Agentsartificial intelligenceChatGPTdecision-making supportdermatologylarge language modelmedicationsecond opinion

Identifiers

PMID38578616
PMCPMC11105123
OpenAlexW4393994738

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.